Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

EGFR-targeted CAR-T immunotherapy

DRUG CLASS:

EGFR-targeted CAR-T immunotherapy

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

EGFR806-specific CAR T-cell therapy (1)

CXCR5 Modified EGFR Targeted CAR-T Cells (0)

EGFR IL12 CART cells (0)

GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)

TmEGFR/IL13Rα2 01 CAR-T (0)

Undisclosed EGFR/B7H3 CAR-T (0)

EGFR806-specific CAR T-cell therapy (1)

CXCR5 Modified EGFR Targeted CAR-T Cells (0)

EGFR IL12 CART cells (0)

GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)

TmEGFR/IL13Rα2 01 CAR-T (0)

Undisclosed EGFR/B7H3 CAR-T (0)

›

EGFR expression

EGFR806-specific CAR T-cell therapy

Sensitive: C2 – Inclusion Criteria

EGFR806-specific CAR T-cell therapy

EGFR806-specific CAR T-cell therapy

Sensitive: C2 – Inclusion Criteria

EGFR806-specific CAR T-cell therapy